Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 16, 2016
Examining Small Intestinal Transit Time as a Function of Age: Is There Evidence to Support Age-Dependent Differences among Children?Anil R Maharaj, Andrea N Edginton
Pharmaceutical Research|July 30, 2015
Assessment of Age-Related Changes in Pediatric Gastrointestinal SolubilityAnil R Maharaj, Andrea N Edginton, Nikoletta Fotaki
Hemodialysis International. International Symposium on Home Hemodialysis|July 22, 2008
Effect of an ethanol/trisodium citrate hemodialysis catheter locking solution on isolates of Candida albicansAnil R Maharaj, Sheryl A Zelenitsky, Lavern M Vercaigne
Journal of Pharmacokinetics and Pharmacodynamics|April 25, 2019
Pitfalls of using numerical predictive checks for population physiologically-based pharmacokinetic model evaluationAnil R Maharaj, Huali Wu, Christoph P Hornik, et al.
British Journal of Anaesthesia|January 21, 2025
Opioid use in treated and untreated obstructive sleep apnoea: remifentanil pharmacokinetics and pharmacodynamics in adult volunteersAnil R Maharaj, Michael C Montana, Christoph P Hornik, et al.
The AAPS Journal|April 17, 2026
Integrating In-vitro Permeability Assays within PBPK Modeling to Predict CNS Distribution of Standard and Engineered AntibodiesSeunghyun Kim, Etienne Lessard, Binbing Ling, et al.
Clinical Pharmacokinetics|August 6, 2017
Improving Pediatric Protein Binding Estimates: An Evaluation of α1-Acid Glycoprotein Maturation in Healthy and Infected SubjectsAnil R Maharaj, Daniel Gonzalez, Michael Cohen-Wolkowiez, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|July 9, 2020
A Randomized, Controlled Pharmacokinetic and Pharmacodynamics Trial of Ambrisentan After Fontan SurgeryKevin D Hill, Anil R Maharaj, Jennifer S Li, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 1, 2019
CNS penetration and pharmacodynamics of the CHK1 inhibitor prexasertib in a mouse Group 3 medulloblastoma modelOlivia Campagne, Abigail Davis, Anil R Maharaj, et al.
Lupus Science & Medicine|January 8, 2022
Hydroxychloroquine PK and exposure-response in pregnancies with lupus: the importance of adherence for neonatal outcomesStephen J Balevic, Daniel Weiner, Megan E B Clowse, et al.
Pageof 3